Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Zunich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chest|June 11, 1992
NIAID programs for asthma research, education, and outreachL J Prograis, K M Zunich
Journal of the American Academy of Dermatology|June 1, 1990
The immunology of HIV infectionK M Zunich, H C Lane
Journal of Clinical Immunology|March 1, 1988
Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effectsK M Zunich, C H Kirkpatrick
Hematology/Oncology Clinics of North America|April 1, 1991
Immunologic abnormalities in HIV infectionK M Zunich, H C Lane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Treatment of human immunodeficiency virus-related thrombocytopenia with intravenous anti-rhesus D immunoglobulinK M Zunich, M Katz, M Woloski, et al.
Lancet (London, England)|November 18, 1995
Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpuraK M Zunich, W S Harkonen, M Woloski, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1989
The effect of theophylline and enprofylline on the late cutaneous response to antigen and compound 48/80K M Zunich, H S Nelson, A Patel, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individualsK M Zunich, H C Lane, R T Davey, et al.
Annals of Internal Medicine|October 1, 1990
Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infectionH C Lane, K M Zunich, W Wilson, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chest|June 11, 1992
NIAID programs for asthma research, education, and outreachL J Prograis, K M Zunich
Journal of the American Academy of Dermatology|June 1, 1990
The immunology of HIV infectionK M Zunich, H C Lane
Journal of Clinical Immunology|March 1, 1988
Methionine-enkephalin as immunomodulator therapy in human immunodeficiency virus infections: clinical and immunological effectsK M Zunich, C H Kirkpatrick
Hematology/Oncology Clinics of North America|April 1, 1991
Immunologic abnormalities in HIV infectionK M Zunich, H C Lane
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Treatment of human immunodeficiency virus-related thrombocytopenia with intravenous anti-rhesus D immunoglobulinK M Zunich, M Katz, M Woloski, et al.
Lancet (London, England)|November 18, 1995
Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpuraK M Zunich, W S Harkonen, M Woloski, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1989
The effect of theophylline and enprofylline on the late cutaneous response to antigen and compound 48/80K M Zunich, H S Nelson, A Patel, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individualsK M Zunich, H C Lane, R T Davey, et al.
Annals of Internal Medicine|October 1, 1990
Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infectionH C Lane, K M Zunich, W Wilson, et al.
The Journal of Infectious Diseases|July 11, 1991
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infectionR T Davey, V J Davey, J A Metcalf, et al.
Pageof 2